Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation

Transplant Proc. 1996 Apr;28(2):1008-10.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Actuarial Analysis
  • Acute Disease
  • Adolescent
  • Adult
  • Aged
  • Chronic Disease
  • Cyclosporine / adverse effects
  • Cyclosporine / therapeutic use*
  • Graft Rejection / prevention & control*
  • Graft Survival*
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Liver Transplantation / immunology*
  • Liver Transplantation / mortality
  • Male
  • Middle Aged
  • Survival Rate
  • Tacrolimus / adverse effects
  • Tacrolimus / therapeutic use*
  • Time Factors
  • Treatment Failure

Substances

  • Immunosuppressive Agents
  • Cyclosporine
  • Tacrolimus